North America Infection Surveillance Solution Systems Market, By Products (Software and Services), Infection Type (Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Central Line-Associated Bloodstream Infections (CLABSI), Catheter Associated Urinary Tract Infection (CAUTI) and others), End User (Hospitals, Long Term Care Facilities, Clinics, Ambulatory Surgical Centers, Academic Institutes, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2028.
Market Analysis and Insights: North America Infection Surveillance Solution Systems Market
The infection surveillance solution systems market is expected to witness market growth at a rate of 14.30% in the forecast period of 2021 to 2028. Data Bridge Market Research report on infection surveillance solution systems market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The growth in healthcare sector globally is escalating the growth of infection surveillance solution systems market.
Infection surveillance solutions are defined as the software and integrated entities that assist in gathering the medical data related to factors causing healthcare associated infections (HAIs) in the medical facilities. These solutions provide features for monitoring, controlling and analyzing along with creating a control action plan to reduce and prevent the HAIs.
The increase in the prevalence of COVID-19 across the region acts as one of the major factors driving the growth of infection surveillance solution systems market. The surge in the adoption of antimicrobial stewardship programs and growing use of automation in healthcare settings accelerate the market growth. The increase in prevalence of hospital-acquired infections (HAIs) and increase in resistance of microbes towards antibiotics further influence the market. Additionally, rise in health consciousness among consumers, high healthcare expenditure, investments to improve healthcare systems and increase in number of surgeries positively affects the infection surveillance solution systems market. Furthermore, consolidation in the healthcare industry and rise in demand for cloud-based software solutions extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the deployment for small healthcare organizations and reluctance among medical professionals to adopt advanced healthcare IT solutions are expected to obstruct the market growth. Shortage of skilled healthcare IT professionals and data security concerns are projected to challenge the infection surveillance solution systems market in the forecast period of 2021-2028.
This infection surveillance solution systems market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on infection surveillance solution systems market Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Infection Surveillance Solution Systems Market Scope and Market Size
The infection surveillance solution systems market is segmented on the basis of products, infection type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of products, the infection surveillance solution systems market is segmented into software and services. Software is further segmented into on premise software and web-based software. Services are further segmented into product support and maintenance, implementation services and training and consulting services.
- On the basis of infection type, the infection surveillance solution systems market is segmented into surgical site infections (SSI), blood stream infections (BSI), urinary tract infections (UTI), central line-associated bloodstream infections (CLABSI), catheter associated urinary tract infection (CAUTI) and others.
On the basis of end user, the infection surveillance solution systems market is segmented into hospitals, long term care facilities, clinics, ambulatory surgical centers, academic institutes, others.
North America Infection Surveillance Solution Systems Market Country Level Analysis
The infection surveillance solution systems market is analyzed and market size insights and trends are provided by country, products, infection type and end user as referenced above.
The countries covered in the North America infection surveillance solution systems market report are U.S., Canada and Mexico in North America.
U.S. dominates the North America infection surveillance solution systems market due to rise in respiratory diseases within the region. Canada is projected to witness high growth during the forecast period of 2021 to 2028 because of the growth in awareness in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
North America infection surveillance solution systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America infection surveillance solution systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America infection surveillance solution systems market. The data is available for historic period 2010-2019.
Competitive Landscape and North America Infection Surveillance Solution Systems Market Share Analysis
The infection surveillance solution systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to infection surveillance solution systems market.
The major players covered in the infection surveillance solution systems market report are BD, Cerner Corporation, Illumina, Inc., RL Solutions,GOJO Industries, Inc., S.C. Johnson & Son, Inc., Baxter, Wolters Kluwer, Vigilanz Corporation, and IBM Corporation, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-